Landscapes / Companies
Kinaset Therapeutics Inc not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials
Trials
1 active
2 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Janus kinase inhibitor |
Phase 2 | 30 Nov 2027Phase 2 trial completes | |||
| How it works | Blocks JAK enzymes that pass on immune signals | ||||
| Next date | 30 Nov 2027 · Phase 2 trial completes | ||||
| Also tested for | Severe Asthma | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021